Advanced search
Publication Cover
Current Eye Research Volume 48, 2023 - Issue 9
Submit an article Journal homepage
186
Views
2
CrossRef citations to date
0
Altmetric
Cornea and Ocular Surface

Long-Term Activity and Safety of a Low-Dose Hydrocortisone Tear Substitute in Patients with Dry Eye Disease

Maurizio Rolandoa Ocular Surface Center, IS.Pre Oftalmica, Genoa, ItalyView further author information
,
Elena Villellab Department of Ophthalmology, ASST Fatebenefratelli SACCO-Università di Milano, Milan, ItalyView further author information
,
Lara Loreggianc International Center for T1D, Pediatric Clinical Research Center “Romeo ed Enrica Invernizzi”, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, ItalyView further author information
,
Sara Marinib Department of Ophthalmology, ASST Fatebenefratelli SACCO-Università di Milano, Milan, ItalyView further author information
,
Cristian Loretellic International Center for T1D, Pediatric Clinical Research Center “Romeo ed Enrica Invernizzi”, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, ItalyView further author information
,
Paolo Fiorinac International Center for T1D, Pediatric Clinical Research Center “Romeo ed Enrica Invernizzi”, Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, Italy;d Nephrology Division, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA;e Endocrinology Division, ASST Fatebenefratelli Sacco, Milan, ItalyView further author information
&
Stefano Barabinof Ocular Surface & Dry Eye Center, Department of Ophthalmology, ASST Fatebenefratelli SACCO, Università di Milano, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6317-8848View further author information
ORCID Icon show all
Pages 799-804 | Received 09 Feb 2023, Accepted 12 May 2023, Published online: 19 Jun 2023

References

  • Reyes JL, Vannan DT, Eksteen B, Avelar IJ, Rodríguez T, González MI, Mendoza AV. Innate and adaptive cell populations driving inflammation in dry eye disease. Mediators Inflamm. 2018;2018:2532314. doi:10.1155/2018/2532314.
  • Tsubota K, Pflugfelder SC, Liu Z, Baudouin C, Kim HM, Messmer EM, Kruse F, Liang L, Carreno-Galeano JT, Rolando M, et al. Defining dry eye from a clinical perspective. IJMS. 2020;21(23):9271. doi:10.3390/ijms21239271.
  • Guo Od LW, Akpek E. The negative effects of dry eye disease on quality of life and visual function. Turk J Med Sci. 2020;50(SI-2):1611–1615. doi:10.3906/sag-2002-143.
  • Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, de Paiva CS, Gomes JAP, Hammitt KM, Jones L, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4):802–812. doi:10.1016/j.jtos.2017.08.003.
  • Barabino S, Aragona P, di Zazzo A, Rolando M, with the contribution of selected ocular surface experts from the Società Italiana di Dacriologia e Superficie Oculare. Updated definition and classification of dry eye disease: renewed proposals using the nominal group and Delphi techniques. Eur J Ophthalmol. 2021;31(1):42–48. doi:10.1177/1120672120960586.
  • Rolando M, Barabino S. The subtle role of para-inflammation in modulating the progression of dry eye disease. Ocul Immunol Inflamm. 2021;29(4):811–816. doi:10.1080/09273948.2021.1906908.
  • Perez VL, Stern ME, Pflugfelder SC. Inflammatory basis for dry eye disease flares. Exp Eye Res. 2020;201:108294. doi:10.1016/j.exer.2020.108294.
  • Rolando M, Barabino S, Mingari C, Moretti S, Giuffrida S, Calabria G. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea. 2005;24(8):951–954. doi:10.1097/01.ico.0000157421.93522.00.
  • Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31(3):271–285. doi:10.1016/j.preteyeres.2012.02.003.
  • Barabino S, Montaldo E, Solignani F, Valente C, Mingari MC, Rolando M. Immune response in the conjunctival epithelium of patients with dry eye. Exp Eye Res. 2010;91(4):524–529. doi:10.1016/j.exer.2010.07.008.
  • Knop N, Knop E. Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT). Dev Ophthalmol. 2010;45:23–39.
  • You IC, Li Y, Jin R, Ahn M, Choi W, Yoon KC. Comparison of 0.1%, 0.18%, and 0.3% hyaluronic acid eye drops in the treatment of experimental dry eye. J Ocul Pharmacol Ther. 2018;34(8):557–564. doi:10.1089/jop.2018.0032.
  • Huynh A, Priefer R. Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology. Carbohydr Res. 2020;489:107950. doi:10.1016/j.carres.2020.107950.
  • Mateo Orobia AJ, Saa J, Ollero Lorenzo A, Herreras JM. Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease. Clin Ophthalmol. 2018;12:453–461. doi:10.2147/OPTH.S157853.
  • Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol. 2006;244(1):109–112. doi:10.1007/s00417-005-0028-1.
  • Montés-Micó R, Cerviño A, Ferrer-Blasco T, García-Lázaro S, Ortí-Navarro S. Optical quality after instillation of eyedrops in dry-eye syndrome. J Cataract Refract Surg. 2010;36(6):935–940. doi:10.1016/j.jcrs.2009.12.044.
  • Ang BCH, Sng JJ, Wang PXH, Htoon HM, Tong LHT. Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis. Sci Rep. 2017;7(1):9013. doi:10.1038/s41598-017-08534-5.
  • Cagini C, Muzi A, Castellucci G, Ragna G, Lupidi M, Alabed HBR, Pellegrino RM. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application. Int J Clin Pract. 2021;75(12):e14987. doi:10.1111/ijcp.14987.
  • Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: the Ocular Surface Disease Index and the symptom assessment in dry eye. Ophthalmology. 2015;122(7):1498–1503. doi:10.1016/j.ophtha.2015.02.037.
  • Bucolo C, Fidilio A, Fresta CG, Lazzara F, Platania CBM, Cantarella G, Di Benedetto G, Burgaletto C, Bernardini R, Piazza C, et al. Ocular pharmacological profile of hydrocortisone in dry eye disease. Front Pharmacol. 2019;10:1240. doi:10.3389/fphar.2019.01240.
  • Rolando M, Barabino S. Are there clinical ways to assess inflammation in dry eye disease? Ocul Immunol Inflamm. 2021;29(6):1183–1189. doi:10.1080/09273948.2021.1916540.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.